Interferon-α therapy following autologous peripheral blood stem cell transplantation for adult T cell leukemia/lymphoma

Acta Haematologica

Volumn 107, Issue 4, 2002, Pages 213-219

  Fujiwara, Hiroshi ^a   Arima, Naomichi ^a,c   Akasaki, Yuichi ^a   Ohtsubo, Hideo ^a   Ozaki, Atsuo ^a   Kukita, Toshimasa ^a   Matsushita, Kakushi ^a   Arimura, Kosei ^a   Suruga, Yukio ^a   Wakamatsu, Shinichi ^a   Matsumoto, Tadashi ^b   Hidaka, Shiroh ^a   Eizuru, Yoshito ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Jiaikai Imamura Hospital   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia; Autologous peripheral blood stem cell transplantation; Cytotoxic T lymphocytes; Interferon

Indexed keywords

ALPHA INTERFERON; CD3 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; IMMUNOTHERAPY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RELAPSE; REMISSION; STEM CELL TRANSPLANTATION; T CELL LEUKEMIA; T CELL LYMPHOMA; TREATMENT OUTCOME; TUMOR CELL;

ABDOMINAL NEOPLASMS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; BIOLOGICAL RESPONSE MODIFIERS; COMBINED MODALITY THERAPY; DOXORUBICIN; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MIDDLE AGED; NITROSOUREA COMPOUNDS; REMISSION INDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, AUTOLOGOUS; VINCRISTINE;

EID: 18444403125     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058317     Document Type: Article

References (36)

1. Adult T-cell leukemia: Clinical and ematological features of 16 cases
2. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma
3. Chemotherapy of ATL
4. Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T cell leukemia/lymphoma
5. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, rani-mustine, and mitoxantrone with granulocyte colony-stimulating factor support
6. Stem cell transplantation for adult T-cell leukemia/ lymphoma
7. Successful treatment of HTLV-1 associated acute adult T-cell leukemia lymphoma by allogeneic bone marrow transplantation
8. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: A case report and review of the literature
9. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984-1987)
10. Long-term maintenance combination chemotherapy with OPEC/MPEC (vincristine or methotrexate, prednisolone, etoposide and cyclophosphamide) or with daily oral etoposide and prednisolone can improve survival and quality of life in adult T-cell leukemia/lymphoma
11. Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization
12. Enhancement of human natural cell-mediated cytotoxicity by interferon
13. Serum deoxythymidine kinase in adult T-cell leukemia-lymphoma and its related disorders
14. Clinical significance of serum thymidine kinase in adult T-cell leukemia and acute myeloid leukemia
15. Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia
16. Detection of preleukemic state of adult T-cell leukemia (pre-ATL) in HTLV-1 carriers
17. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
18. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma
19. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma
20. Expression of P-glycoprotein in adult T-cell leukemia cells
21. Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: Implications for adoptive immunotherapy
22. CTL-defined cancer vaccines: Perspectives for active immunotherapeutic interventions in minimal residual disease
23. T cell memory against colon carcinoma is long-lived in the absence of antigen
24. An HLA-A2 polyepitope vaccine for melanoma immunotherapy
25. Dendritic cell transduced with wild-type p53 gene elicit potent anti-tumor immune responses
26. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16E7
27. Variability of the alloreactive T-cell response to human leukemia blasts
28. Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia
29. Generation of donor-derived antileukemic cytotoxic T-lymphocyte response for treatment of relapsed leukemia after allogeneic HLA-identical bone marrow transplantation
30. Cyclosporin A/alpha inter-feron-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukemia: A clinico-pathological study
31. IFN-alpha-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs
32. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon
33. Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells
34. Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells
35. Effect of human lymphoblast interferon in adult T-cell leukemia and non-Hodgkin's lymphoma
36. Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphma patients